Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors

(marketscreener.com) PHILADELPHIA, Oct. 03, 2022 -- Century Therapeutics , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, today announced the appointment of Daphne Quimi and Timothy Walbert to the Company’s Board of Directors. Ms. Quimi is currently Chief Financial Officer of Amicus...https://www.marketscreener.com/quote/stock/CENTURY-THERAPEUTICS-INC-123820661/news/Century-Therapeutics-Announces-Appointment-of-Daphne-Quimi-and-Timothy-Walbert-to-its-Board-of-Direc-41913578/?utm_medium=RSS&utm_content=20221003